Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1 1

Status

Recruiting 3Completed 3Active not recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Head and Neck Neoplasms 41Squamous Cell Carcinoma of Head and Neck 37Prostatic Neoplasms 16Nasopharyngeal Carcinoma 12Carcinoma, Non-Small-Cell Lung 12Glioblastoma 11Uterine Cervical Neoplasms 10Gliosarcoma 10Brain Neoplasms 10Neoplasm Metastasis 9Carcinoma, Squamous Cell 8Breast Neoplasms 8Rectal Neoplasms 7Pancreatic Neoplasms 7Glioma 7Carcinoma 7Tongue Neoplasms 6Radiation Injuries 6Oropharyngeal Neoplasms 6Neoplasms 6Lung Neoplasms 6Astrocytoma 6Sarcoma 5Nasopharyngeal Neoplasms 5Papillomavirus Infections 4Endometrial Neoplasms 4Salivary Gland Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Laryngeal Neoplasms 3

Interventions

Cisplatin 7Cetuximab 6Radiotherapy 5Fluorouracil 4Radiotherapy, Intensity-Modulated 3Docetaxel 3pembrolizumab 2Radiation 2Psychiatric Rehabilitation 2Nicotine 2Hydroxyurea 2Drug Therapy 2Counseling 2Celecoxib 2Bupropion 2sodium thiosulfate 1sargramostim 1motexafin gadolinium 1eniluracil 1durvalumab 1Zinc Oxide 1Varenicline 1Tobacco Use Cessation Devices 1Surgical Procedures, Operative 1Semaxinib 1Referral and Consultation 1Protons 1Proton Therapy 1Polymerase Chain Reaction 1Pilocarpine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Hypopharyngeal Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT03258554 2026-06-02

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

National Cancer Institute (NCI)

Phase 2/3 Completed
196 enrolled 31 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT02113878 2024-11-05

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

Dana-Farber Cancer Institute

Phase 1 Completed
23 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Nasopharyngeal Neoplasms

NCT00833261 2020-08-21

Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer

University of Texas Southwestern Medical Center

Phase 2 Completed
37 enrolled 6 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Tongue Neoplasms, Carcinoma, Verrucous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡